Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Mononuclear Cells for Dilated Cardiomyopathy in Children
NCT04893629Terminated
- Sponsor
- Damascus University
- Start
- May 2021
- Primary completion
- Nov 2024
- Countries
- 1
01
Overview
Randomised, open-label trial in dilated cardiomyopathy (DCM), sponsored by Damascus University. Primary endpoint: Left Ventricle Ejection Fraction at 6 months. Started May 2021; status: terminated.
02
Conditions
dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT04893629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04893629.